0001567619-22-002079.txt : 20220131 0001567619-22-002079.hdr.sgml : 20220131 20220131164559 ACCESSION NUMBER: 0001567619-22-002079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220127 FILED AS OF DATE: 20220131 DATE AS OF CHANGE: 20220131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yorke Justin W CENTRAL INDEX KEY: 0001361896 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39531 FILM NUMBER: 22574615 MAIL ADDRESS: STREET 1: C/O JMG EXPLORATION STREET 2: 180 SOUTH LAKE AVENUE CITY: PASADENA STATE: CA ZIP: 91101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001533743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451539785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 BUSINESS PHONE: 443-776-3133 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 FORMER COMPANY: FORMER CONFORMED NAME: Heatwurx, Inc. DATE OF NAME CHANGE: 20111028 4 1 doc1.xml FORM 4 X0306 4 2022-01-27 0 0001533743 Processa Pharmaceuticals, Inc. PCSA 0001361896 Yorke Justin W C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076 1 0 0 0 Common Stock 2022-01-27 4 S 0 1854 3.30 D 532563 I By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC Common Stock 9323 D The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.26 to $3.37, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. /s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact 2022-01-31